These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Plasmalipoproteins and atherosclerosis. Schettler G Arch Inst Cardiol Mex; 1975; 45(3):335-43. PubMed ID: 168820 [TBL] [Abstract][Full Text] [Related]
23. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498 [TBL] [Abstract][Full Text] [Related]
25. [Arteriosclerosis. IV. Treatment of dyslipoproteinemia]. Cybulska B; Kłosiewicz-Latoszek L Wiad Lek; 1985 Sep; 38(17):1251-7. PubMed ID: 4090499 [No Abstract] [Full Text] [Related]
26. [New prospects in the study of the relations between hypertension and atherosclerosis]. Eliseev OM Ter Arkh; 1994; 66(4):71-6. PubMed ID: 8016737 [No Abstract] [Full Text] [Related]
27. Hyperapobetalipoproteinaemia: an emerging risk factor for atherosclerosis. Thompson GR; Trayner IA; Allaway SL; Robinson D; Ritchie CD Monogr Atheroscler; 1986; 14():129-31. PubMed ID: 3736551 [No Abstract] [Full Text] [Related]
28. [Do very low density lipoproteins (VLDL) participate in atherogenesis?]. Cybulska B Kardiol Pol; 1992 Aug; 37(8):104-7. PubMed ID: 1434325 [No Abstract] [Full Text] [Related]
29. [Insulinemia, fatty acids in plasma lipids and lipoproteins and oxidation of VLDL and LDL in hyperlipidemia]. Zeman M; Zák A; Tvrzická E; Buchtíková M; Stípek S; Pousek L Sb Lek; 2000; 101(1):77-82. PubMed ID: 10953635 [TBL] [Abstract][Full Text] [Related]
30. Atherosclerosis and the low density lipoproteins of plasma. Faergeman O Scand J Haematol Suppl; 1979; 34():116-8. PubMed ID: 225794 [No Abstract] [Full Text] [Related]
31. [Characteristics of the indicators of the lipoprotein spectrum of blood and the main risk factors of the development of arteriosclerosis among university students in different regions of the USSR]. Olfer'ev AM; Shamarin VM; Petrosian KIu; Koval' SN; Konobeevskaia IN; Aripov BS; Zadoia NA; Nazarenko IL; Kanskaia NV; Kulikov SM Sov Med; 1991; (9):46-9. PubMed ID: 1839195 [No Abstract] [Full Text] [Related]
32. Elevated levels of chylomicron- and VLDL-remnants leads to atherosclerosis in apoE transgenic mice. van Vlijmen BJ; van Ree JH; Frants RR; Hofker MH; Havekes LM Z Gastroenterol; 1996 Jun; 34 Suppl 3():113-5. PubMed ID: 8767483 [No Abstract] [Full Text] [Related]
33. [Lowering of lipids: a true prevention?--a justified therapy?--a true controversy?]. Stähelin HB Schweiz Med Wochenschr; 1980 Mar; 110(13):478-84. PubMed ID: 7375898 [TBL] [Abstract][Full Text] [Related]
35. [A case of Addison-Gull syndrome]. Gorbanev EA Klin Med (Mosk); 1991 Sep; 69(9):79-81. PubMed ID: 1803163 [No Abstract] [Full Text] [Related]
36. [Arteriosclerosis. I. Pathogenesis of atheromatous focus]. Szostak WB; Kłosiewicz-latoszek L; Cybulska B Wiad Lek; 1985 Jul; 38(14):1031-7. PubMed ID: 3907148 [No Abstract] [Full Text] [Related]
37. [Lowering of resistance to oxidation of VLDL lipoproteins and some subfractions of LDL lipoproteins in patients with non-insulin-dependent diabetes mellitus]. Ragino IuI; Dushkin MI; Nikitin IuP Ter Arkh; 1999; 71(4):52-5. PubMed ID: 10358865 [TBL] [Abstract][Full Text] [Related]
38. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W; Reuter W Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
39. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis]. Gasilin VS; Kurdanov KhA Ter Arkh; 1981; 53(8):130-8. PubMed ID: 7027512 [No Abstract] [Full Text] [Related]
40. [Dyslipoproteinemia and hyperuricemia in podagra and urinary calculi]. Barats IS Ter Arkh; 1982; 54(10):52-4. PubMed ID: 7179120 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]